Therefore, treatment strategies such as initial therapy with AIs, which reduce early distant recurrence events, can be expected to improve long-term survival outcomes. Switching to an AI following ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

Neoantigen-targeting PCVs are highly immunogenic in high-risk clear cell RCC and can target key driver mutations and induce antitumor immunity.

A new Moffitt Cancer Center study has identified a specific immune response that may prevent the spread of breast cancer ...

Downgrade to “REDUCE.” We cut our estimates by 5-25% over the forecast period to factor in the headwinds in the legacy transfer case business and slowdown in the EV business. Further ...

If the tumor recurrence is diagnosed in an area that surgeons can safely operate on, a second surgery might reduce the tumor size. This approach can alleviate pressure ... Advanced techniques like ...

Almost a month after Target said it was ending some of its diversity, equity and inclusion (DEI) programs, the company is facing backlash from customers, the heirs to one of its founders and civil ...

Boryung announced on the 18th the launch of 'Ravetricks Capsule', a combination of aspirin and rabeprazole. Ravetricks is a ...

However, as the ordering momentum has slowed majorly compared to previous years (from a CAGR of 23 per cent between CY20 and CY23 to just 5 per cent in CY24), Nomura has downgraded ABB India to a ...